Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 814 across all filing types
Latest filing 2024-08-23 Director's Dealing
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Comunicato Internal Dealing
Director's Dealing Classification · 100% confidence The document is titled 'Comunicato Internal Dealing' (Internal Dealing Communication) and contains a template for the notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs). The content explicitly details transactions made by an executive (Carlo Rosa) related to stock options. This directly corresponds to the definition of Director's Dealing (insider trades by directors and executives). Therefore, the appropriate filing type code is DIRS.
2024-08-23 Italian
Comunicato Internal Dealing
Director's Dealing Classification · 100% confidence The document is titled 'Comunicato Internal Dealing' (Internal Dealing Communication) and uses the template for 'notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This directly corresponds to the reporting of personal share transactions by company directors and executives, which is classified as Director's Dealing. Based on the definitions, this matches the description for Director's Dealing (Code: DIRS).
2024-08-23 Italian
Comunicato Internal Dealing
Director's Dealing Classification · 100% confidence The document is titled 'Modello di notifica e di comunicazione al pubblico delle operazioni effettuate da persone che esercitano funzioni di amministrazione, di controllo o di direzione e da persone a loro strettamente associate' (Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). The 'Oggetto' (Subject) field explicitly states 'Cominucato Internal Dealing'. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). Therefore, the filing type is DIRS.
2024-08-21 Italian
Comunicato Internal Dealing
Director's Dealing Classification · 100% confidence The document text contains a table with the header 'Oggetto: Comunicato Internal Dealing' (Subject: Internal Dealing Announcement) and uses the template 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This explicitly indicates a report concerning personal share transactions by company directors and executives (insider trades). This directly corresponds to the definition for Director's Dealing (DIRS). The document is short and refers to an attachment ('Vedasi allegato'), but the core content is the notification structure itself, making DIRS the most specific classification over a general RPA or RNS.
2024-08-02 Italian
Relazione Finanziaria Semestrale del Gruppo DiaSorin al 30 giugno 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Relazione Finanziaria Semestrale 2024' (Half-Year Financial Report 2024) for the company Diasorin. It contains comprehensive financial statements, including the consolidated income statement, balance sheet, cash flow statement, and explanatory notes for the period ending June 30, 2024. As it is a full interim financial report containing substantive financial data and analysis, it falls under the 'Interim / Quarterly Report' category. H1 2024
2024-08-02 Italian
DiaSorin S.p.A. - Allegato 3F
Transaction in Own Shares Classification · 98% confidence The document is a formal disclosure titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (Disclosure Form for Transactions in the Issuer's Securities) from DiaSorin S.p.A., dated August 1, 2024, referencing transactions in July 2024. Section 2 details specific transactions (sales, 'V') of the company's own shares ('Azioni') related to the exercise of stock options. Section 3 discusses the program for the purchase and sale of treasury shares. This content directly relates to the company managing its own stock, which falls under the category of transactions in own shares (share repurchase/issuance). This matches the definition for 'Transaction in Own Shares' (POS).
2024-08-01 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.